New Trials Stage of Chinese Covid-19 Vaccine Authorized by ANVISA

According to ANVISA, the authorization was requested by the Butantan Institute, in São Paulo. Nine thousand volunteers will be selected from different regions of Brazil.

RIO DE JANEIRO, BRAZIL - The National Health Regulatory Agency (ANVISA) on Friday, July 3rd, released the third trial stage of the vaccine against the novel coronavirus developed by Chinese

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?